Report
Richard Williamson

Riber - Order intake accelerating

Riber’s Q321 revenues were up 11% year-on-year. This growth partly offset the 20% contraction in H121 caused by a slowdown in MBE system orders during the coronavirus pandemic in FY20. Revenues for the nine months ended September 2021 (Q321) totalled €15.8m, 9% lower year-on-year. Order intake has improved substantially since FY20, but the resultant production schedule means that system deliveries are concentrated into Q421. MBE system orders continued to pick up in Q321, so management has reiterated its FY21 guidance of over €30.0m revenues and operating income of €1.2m. We leave our estimates unchanged.
Underlying
Riber SA

Riber and its subsidiaries are engaged in the design, produce, sale and maintain molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. In addition to MBE systems, a comprehensive range of MBE related-components is also available. These equipments are essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to Organic Light-Emitting Diode flat screens and new generation thin layer solar cells.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Analysts
Richard Williamson

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch